NCT06199934View on ClinicalTrials.gov

Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data

CompletedOBSERVATIONAL
Enrollment

19,853,610

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
SARS-CoV-2COVID-19 Vaccines
Interventions
BIOLOGICAL

Vaccination

BNT162b2 vaccination

Trial Locations (1)

10001

Pfizer Global Headquarters, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06199934 - Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data | Biotech Hunter | Biotech Hunter